VIENNA -- Cigarette smoking by patients infected with human immunodeficiency virus (HIV) does not appear to impact therapeutic levels of the protease inhibitor atazanavir (Reyataz), researchers said here at the 2010 International AIDS Conference.
VIENNA -- Cigarette smoking by patients infected with human immunodeficiency virus (HIV) does not appear to impact therapeutic levels of the protease inhibitor atazanavir (Reyataz), researchers said here at the 2010 International AIDS Conference.